This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Guangzhou Henovcom Bioscience Co. Ltd. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yanwei Chen - Innovator in Pharmaceutical Science
Introduction
Yanwei Chen is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of novel compounds that target specific diseases. His work focuses on creating innovative solutions that can improve health outcomes for patients.
Latest Patents
Yanwei Chen holds a patent for an aromatic heterocyclic compound, which serves as an Autotaxin inhibitor. This patent includes a pharmaceutical composition comprising the compound and its use in treating diseases characterized by Autotaxin overexpression in mammals. The compound is defined by a specific formula, and it may exist in various forms, including pharmaceutically acceptable salts and stereoisomers. This innovation highlights his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Yanwei Chen has been associated with Guangzhou Henovcom Bioscience Co. Ltd. His role at the company has allowed him to collaborate with other talented professionals in the field. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Yanwei Chen has worked alongside notable colleagues, including Lijun Zhang and Jufu Zhang. Their collaborative efforts have contributed to the advancement of innovative solutions in pharmaceutical science.
Conclusion
In summary, Yanwei Chen is an influential inventor whose work in developing pharmaceutical compounds has the potential to make a significant impact on healthcare. His innovative approach and dedication to research continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile